Lenograstim reduces the incidence of febrile episodes, when compared with filgrastim, in multiple myeloma patients undergoing stem cell mobilization.
about
Pegylated granulocyte colony stimulating factor versus non-pegylated granulocyte colony stimulating factor for peripheral stem cell mobilizationPegylated granulocyte colony stimulating factor versus non-pegylated granulocyte colony stimulating factor for peripheral stem cell mobilizationFilgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignanciesOptimal use of recombinant granulocyte colony-stimulating factor with chemotherapy for solid tumors.Prophylaxis of infectious complications with colony-stimulating factors in adult cancer patients undergoing chemotherapy-evidence-based guidelines from the Infectious Diseases Working Party AGIHO of the German Society for Haematology and Medical OncLecture: management of chemotherapy-induced febrile neutropenia; guidelines and colony stimulating factors.
P2860
Lenograstim reduces the incidence of febrile episodes, when compared with filgrastim, in multiple myeloma patients undergoing stem cell mobilization.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Lenograstim reduces the incide ...... rgoing stem cell mobilization.
@en
type
label
Lenograstim reduces the incide ...... rgoing stem cell mobilization.
@en
prefLabel
Lenograstim reduces the incide ...... rgoing stem cell mobilization.
@en
P2093
P1433
P1476
Lenograstim reduces the incide ...... rgoing stem cell mobilization.
@en
P2093
Clotilde Cangialosi
Domenico Pastore
Elisa Mauro
Emerenziana Marturano
Enrico Orciuolo
Giuseppe Milone
Giuseppe Pietrantuono
Maria Rosaria De Paolis
Mario Petrini
Nicola Di Renzo
P304
P356
10.1016/J.LEUKRES.2010.10.029
P577
2010-12-04T00:00:00Z